Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19
INTRODUCTION. The risk of liver damage correlates with the severity of COVID-19. However, a growing number of studies have shown an association between liver function impairment and combinations of medicinal products used to treat COVID-19.AIM. The study aimed to analyse the annual consumption of me...
Saved in:
Main Authors: | V. I. Petrov (Author), A. Yu. Ryazanova (Author), N. S. Tokareva (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in the treatment of drug-induced liver injury with natural products
by: Yuan-kai Sun, et al.
Published: (2022) -
Drug-Induced Liver Injury: Mechanisms and Counteracting Herbal-Derived Products
by: Doha Ismail Alrawi, et al.
Published: (2024) -
Idiosyncratic Drug-Induced Liver Injury: From Pathogenesis to Risk Reduction
by: I. A. Mazerkina
Published: (2023) -
CLINICAL AND ECONOMIC ANALYSIS OF GENETICALLY ENGINEERED BIOLOGICS CONSUMPTION BY PATIENTS WITH COVID-19
by: V. I. Petrov, et al.
Published: (2022) -
Management of Drug-Induced Liver Injury with Persian Medicine: Case Report
by: Amir-Mohammad Jaladat, et al.
Published: (2022)